Latest Clovis Oncology Inc (CLVS) Headlines
'Fast Money' Recap: China Syndrome
at The Street - Thu Mar 06, 4:00AM CST
The trading panel discussed how to invest in and around China.
Why Clovis Oncology, Inc. Shares Jumped
Sean Williams, The Motley Fool - Motley Fool - Fri Feb 28, 12:21PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Clovis Oncology , a clinical-stage...
Wood Resources International LLC: China imported logs and lumber for a record nine billion dollars in 2013, with North America, Russia and New Zealand being the major suppliers
Business Wire - Fri Feb 28, 2:45AM CST
Importation of logs and lumber to China reached a new record in 2013 with lumber imports being up 19% and log imports increasing 23% from 2012, as reported in the Wood Resource Quarterly. North America, Russia and New Zealand were the major supplying countries but Sweden, Finland, Ukraine, Chile and Australia saw the biggest increases in market share
Clovis Oncology Announces 2013 Operating Results and Expands CO-1686 Development Program
Business Wire - Thu Feb 27, 3:02PM CST
--Potential to accelerate NDA submission timeline
Research and Markets: China Polyaniline (PAN) Market 2014 Report
Business Wire - Tue Feb 25, 6:31AM CST
Research and Markets (http://www.researchandmarkets.com/research/6s8blr/research_and) has announced the addition of the "Research and Investment Prospect Evaluation of China Polyaniline (PAN) Market, 2014" report to their offering.
Clovis Oncology to Announce Fourth Quarter/Year End 2013 Financial Results and Host Webcast Conference Call on February 27
GlobeNewswire - Tue Feb 18, 3:05PM CST
Clovis Oncology, Inc. (Nasdaq:CLVS) will announce its fourth quarter/year end 2013 financial results on Thursday, February 27, 2014, after the close of the U.S. financial markets. Clovis' senior management will host a conference call and live audio webcast on Thursday, February 27, at 4:30 p.m. ET to discuss the company's results in greater detail.
Commit To Purchase Clovis Oncology At $50, Earn 20.8% Annualized Using Options
at The Street - Tue Feb 18, 10:26AM CST
Investors eyeing a purchase of Clovis Oncology shares, but tentative about paying the going market price of $69.87/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in...
Nexstim Announces New Stroke Therapy Produced Significant Gains in Motor Function Post-Stroke
Business Wire - Fri Feb 14, 7:50AM CST
Every two seconds someone in the world suffers a stroke. A study from the Rehabilitation Institute of Chicago approached stroke rehabilitation through a new combination of therapies which produced significantly greater gains in patients' motor function 6 months post-stroke. The combination of non-invasive navigated transcranial stimulation (nTMS) along with occupational therapy (OT) opened the door to improving the quality of life for stroke survivors. The study presented Thursday at the American Heart Association (AHA) and the American Stroke Association's (ASA) International Stroke Conference, yielded results from the active group of improved function by 13+ points in UEFM score.
Critical Alerts For 3D Systems, JA Solar, Apollo Group, Illumina, and Clovis Oncology Released By InvestorsObserver
PR Newswire - Thu Feb 13, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for DDD, JASO, APOL, ILMN, and CLVS.
Clovis Oncology to Present at the 2014 Leerink Global Healthcare Conference
Business Wire - Thu Feb 06, 7:00AM CST
Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that Patrick J. Mahaffy, the Company's president and CEO, will present at the 2014 Leerink Global Healthcare Conference on Thursday, February 13, at 11:25am MST. The conference is being held at the Waldorf Astoria in New York City.
The Past, Present, and Future of Lung Cancer Treatments
Leo Sun, The Motley Fool - Motley Fool - Sat Jan 25, 9:30AM CST
Follow @leokornsun // full story)
'Fast Money' Recap: Negative Pre-Announcements
at The Street - Sat Jan 18, 4:00AM CST
The trading panel discussed whether investors should worry that 94 companies on the S&P, a seven-year high, expect lower earnings.
Critical Alerts For Ford, Clovis Oncology, Johnson Controls, Juniper Networks, and Sarepta Therapeutics Released By InvestorsObserver
PR Newswire - Tue Jan 14, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for F, CLVS, JCI, JNPR, and SRPT.
J.P. Morgan Healthcare Confab Live Blog: Day One
at The Street - Mon Jan 13, 9:19AM CST
TheStreet's Adam Feuerstein is providing live coverage all week from the biotech sector's most important investor conference.
Keep An Eye on AstraZeneca plc (ADR), Bristol-Myers Squibb Co., Clovis Oncology Inc., and Alexion Ph
Leo Sun, The Motley Fool - Motley Fool - Mon Jan 13, 8:17AM CST
Follow @leokornsun // full story)
The J.P. Morgan Healthcare Confab Monday Morning News Dump
at The Street - Mon Jan 13, 8:06AM CST
It's still pre-dawn in San Francisco, a few hours from the start of the J.P. Morgan Healthcare Conference, but that hasn't stopped biotech and drug companies from dumping a ton of news and announcements into the market. Here's a brief look at what's...
3 Stocks Spiking on Big Volume
at The Street - Mon Jan 13, 6:00AM CST
Often when above-average volume moves into an equity, it precedes a large spike in volatility.
Clovis Oncology Announces 2014 Objectives and Financial Guidance
Business Wire - Mon Jan 13, 4:59AM CST
Clovis Oncology, Inc. (NASDAQ: CLVS) today announced anticipated development milestones and financial guidance for 2014. Clovis currently has three clinical development programs underway, and expects to initiate four registration studies for two of its programs during the first half of 2014.
'Fast Money' Recap: Confused Investors
at The Street - Sat Jan 11, 4:00AM CST
The trading panel looked at gold, stocks and what to do next.
Can The Uptrend Continue for Clovis Oncology Inc (CLVS)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 10, 6:52AM CST
Can The Uptrend Continue for Clovis Oncology Inc (CLVS)?
'Fast Money' Recap: China Syndrome
at The Street - Thu Mar 06, 4:00AM CST
The trading panel discussed how to invest in and around China.
Why Clovis Oncology, Inc. Shares Jumped
Sean Williams, The Motley Fool - Motley Fool - Fri Feb 28, 12:21PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Clovis Oncology , a clinical-stage...
Wood Resources International LLC: China imported logs and lumber for a record nine billion dollars in 2013, with North America, Russia and New Zealand being the major suppliers
Business Wire - Fri Feb 28, 2:45AM CST
Importation of logs and lumber to China reached a new record in 2013 with lumber imports being up 19% and log imports increasing 23% from 2012, as reported in the Wood Resource Quarterly. North America, Russia and New Zealand were the major supplying countries but Sweden, Finland, Ukraine, Chile and Australia saw the biggest increases in market share
Clovis Oncology Announces 2013 Operating Results and Expands CO-1686 Development Program
Business Wire - Thu Feb 27, 3:02PM CST
--Potential to accelerate NDA submission timeline
Research and Markets: China Polyaniline (PAN) Market 2014 Report
Business Wire - Tue Feb 25, 6:31AM CST
Research and Markets (http://www.researchandmarkets.com/research/6s8blr/research_and) has announced the addition of the "Research and Investment Prospect Evaluation of China Polyaniline (PAN) Market, 2014" report to their offering.
Clovis Oncology to Announce Fourth Quarter/Year End 2013 Financial Results and Host Webcast Conference Call on February 27
GlobeNewswire - Tue Feb 18, 3:05PM CST
Clovis Oncology, Inc. (Nasdaq:CLVS) will announce its fourth quarter/year end 2013 financial results on Thursday, February 27, 2014, after the close of the U.S. financial markets. Clovis' senior management will host a conference call and live audio webcast on Thursday, February 27, at 4:30 p.m. ET to discuss the company's results in greater detail.
Commit To Purchase Clovis Oncology At $50, Earn 20.8% Annualized Using Options
at The Street - Tue Feb 18, 10:26AM CST
Investors eyeing a purchase of Clovis Oncology shares, but tentative about paying the going market price of $69.87/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in...
Nexstim Announces New Stroke Therapy Produced Significant Gains in Motor Function Post-Stroke
Business Wire - Fri Feb 14, 7:50AM CST
Every two seconds someone in the world suffers a stroke. A study from the Rehabilitation Institute of Chicago approached stroke rehabilitation through a new combination of therapies which produced significantly greater gains in patients' motor function 6 months post-stroke. The combination of non-invasive navigated transcranial stimulation (nTMS) along with occupational therapy (OT) opened the door to improving the quality of life for stroke survivors. The study presented Thursday at the American Heart Association (AHA) and the American Stroke Association's (ASA) International Stroke Conference, yielded results from the active group of improved function by 13+ points in UEFM score.
Critical Alerts For 3D Systems, JA Solar, Apollo Group, Illumina, and Clovis Oncology Released By InvestorsObserver
PR Newswire - Thu Feb 13, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for DDD, JASO, APOL, ILMN, and CLVS.
Clovis Oncology to Present at the 2014 Leerink Global Healthcare Conference
Business Wire - Thu Feb 06, 7:00AM CST
Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that Patrick J. Mahaffy, the Company's president and CEO, will present at the 2014 Leerink Global Healthcare Conference on Thursday, February 13, at 11:25am MST. The conference is being held at the Waldorf Astoria in New York City.
The Past, Present, and Future of Lung Cancer Treatments
Leo Sun, The Motley Fool - Motley Fool - Sat Jan 25, 9:30AM CST
Follow @leokornsun // full story)
'Fast Money' Recap: Negative Pre-Announcements
at The Street - Sat Jan 18, 4:00AM CST
The trading panel discussed whether investors should worry that 94 companies on the S&P, a seven-year high, expect lower earnings.
Critical Alerts For Ford, Clovis Oncology, Johnson Controls, Juniper Networks, and Sarepta Therapeutics Released By InvestorsObserver
PR Newswire - Tue Jan 14, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for F, CLVS, JCI, JNPR, and SRPT.
J.P. Morgan Healthcare Confab Live Blog: Day One
at The Street - Mon Jan 13, 9:19AM CST
TheStreet's Adam Feuerstein is providing live coverage all week from the biotech sector's most important investor conference.
Keep An Eye on AstraZeneca plc (ADR), Bristol-Myers Squibb Co., Clovis Oncology Inc., and Alexion Ph
Leo Sun, The Motley Fool - Motley Fool - Mon Jan 13, 8:17AM CST
Follow @leokornsun // full story)
The J.P. Morgan Healthcare Confab Monday Morning News Dump
at The Street - Mon Jan 13, 8:06AM CST
It's still pre-dawn in San Francisco, a few hours from the start of the J.P. Morgan Healthcare Conference, but that hasn't stopped biotech and drug companies from dumping a ton of news and announcements into the market. Here's a brief look at what's...
3 Stocks Spiking on Big Volume
at The Street - Mon Jan 13, 6:00AM CST
Often when above-average volume moves into an equity, it precedes a large spike in volatility.
Clovis Oncology Announces 2014 Objectives and Financial Guidance
Business Wire - Mon Jan 13, 4:59AM CST
Clovis Oncology, Inc. (NASDAQ: CLVS) today announced anticipated development milestones and financial guidance for 2014. Clovis currently has three clinical development programs underway, and expects to initiate four registration studies for two of its programs during the first half of 2014.
'Fast Money' Recap: Confused Investors
at The Street - Sat Jan 11, 4:00AM CST
The trading panel looked at gold, stocks and what to do next.
Can The Uptrend Continue for Clovis Oncology Inc (CLVS)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 10, 6:52AM CST
Can The Uptrend Continue for Clovis Oncology Inc (CLVS)?
